287 related articles for article (PubMed ID: 28366726)
41. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.
Hu CM; Zhang L
Biochem Pharmacol; 2012 Apr; 83(8):1104-11. PubMed ID: 22285912
[TBL] [Abstract][Full Text] [Related]
42. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
43. Capsaicinoids enhance chemosensitivity to chemotherapeutic drugs.
Friedman JR; Richbart SD; Merritt JC; Perry HE; Brown KC; Akers AT; Nolan NA; Stevenson CD; Hurley JD; Miles SL; Tirona MT; Valentovic MA; Dasgupta P
Adv Cancer Res; 2019; 144():263-298. PubMed ID: 31349900
[TBL] [Abstract][Full Text] [Related]
44. Natural products to prevent drug resistance in cancer chemotherapy: a review.
Yuan R; Hou Y; Sun W; Yu J; Liu X; Niu Y; Lu JJ; Chen X
Ann N Y Acad Sci; 2017 Aug; 1401(1):19-27. PubMed ID: 28891091
[TBL] [Abstract][Full Text] [Related]
45. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells.
Sadava D; Phillips T; Lin C; Kane SE
Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669
[TBL] [Abstract][Full Text] [Related]
46. Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells.
Suberu JO; Romero-Canelón I; Sullivan N; Lapkin AA; Barker GC
ChemMedChem; 2014 Dec; 9(12):2791-7. PubMed ID: 25209896
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment.
Li D; Zhang J; Zhao X
Cancer Invest; 2021 Sep; 39(8):675-684. PubMed ID: 34241563
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Li Y; Zhou X; Liu J; Yuan X; He Q
Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
[TBL] [Abstract][Full Text] [Related]
49. Informatics of drug synergism in naturally occurring anticancer agents.
Ghavami G; Kazemali MR; Sardari S
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):26-44. PubMed ID: 21110822
[TBL] [Abstract][Full Text] [Related]
50. Nano Strategies for Artemisinin Derivatives to Enhance Reverse Efficiency of Multidrug Resistance in Breast Cancer.
Zhang X; Li N; Zhang G; Li J; Liu Y; Wang M; Ren X
Curr Pharm Des; 2023; 29(43):3458-3466. PubMed ID: 38270162
[TBL] [Abstract][Full Text] [Related]
51. The clinical pharmacology of etoposide: an update.
Joel S
Cancer Treat Rev; 1996 May; 22(3):179-221. PubMed ID: 8841390
[No Abstract] [Full Text] [Related]
52. "Discovery and development of new anticancer drugs inspired from natural product leads" part 1.
Rane R; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):536. PubMed ID: 25981059
[No Abstract] [Full Text] [Related]
53. Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities.
Chiu GN; Wong MY; Ling LU; Shaikh IM; Tan KB; Chaudhury A; Tan BJ
Curr Drug Metab; 2009 Oct; 10(8):861-74. PubMed ID: 20214582
[TBL] [Abstract][Full Text] [Related]
54. Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy.
Zhu S; Yu Q; Huo C; Li Y; He L; Ran B; Chen J; Li Y; Liu W
Curr Med Chem; 2021; 28(2):329-345. PubMed ID: 31965935
[TBL] [Abstract][Full Text] [Related]
55. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.
Wong YK; Xu C; Kalesh KA; He Y; Lin Q; Wong WSF; Shen HM; Wang J
Med Res Rev; 2017 Nov; 37(6):1492-1517. PubMed ID: 28643446
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic drugs in lung cancer.
Wattanathamsan O; Hayakawa Y; Pongrakhananon V
Phytother Res; 2019 Oct; 33(10):2531-2547. PubMed ID: 31293008
[TBL] [Abstract][Full Text] [Related]
57. Anticancer Hybrid Combinations: Mechanisms of Action, Implications and Future Perspectives.
Domínguez-Martín EM; Díaz-Lanza AM; Faustino CMC
Curr Pharm Des; 2018; 24(36):4312-4333. PubMed ID: 30636587
[TBL] [Abstract][Full Text] [Related]
58. Development of artemisinin compounds for cancer treatment.
Lai HC; Singh NP; Sasaki T
Invest New Drugs; 2013 Feb; 31(1):230-46. PubMed ID: 22935909
[TBL] [Abstract][Full Text] [Related]
59. Demonstrating the validity of natural products as anti-infective drugs.
Schuster BG
J Altern Complement Med; 2001; 7 Suppl 1():S73-82. PubMed ID: 11822638
[TBL] [Abstract][Full Text] [Related]
60. Repurposing of artemisinin-type drugs for the treatment of acute leukemia.
Lu X; Efferth T
Semin Cancer Biol; 2021 Jan; 68():291-312. PubMed ID: 32485311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
